Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jay Flatley
AddedMar 31, 2024
UpdatedMay 31, 2026
Jay Flatley

Jay Flatley

Board Member, Denali Therapeutics

Crunchbase

Jay Flatley's Career

Denali Therapeutics
Denali Therapeutics

San Francisco, CA, US

Board Member· Board
Rivian Automotive
Rivian Automotive

Irvine, CA, US

Board Member· Board
Illumina
Illumina

San Diego, CA, US

Board Member· Board
Iridia
Iridia

Carlsbad, CA, US

Board Member· Board
Helixis
Helixis

Carlsbad, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jay Flatley's Career

Denali Therapeutics
Denali Therapeutics
Public$622M4272015San Francisco, CA, US
Board Member· Board

Leadership at Denali Therapeutics

Vicki SatoVicki SatoBoard Member
Tom StockyTom StockyBoard Member
Steve KrognesSteve KrognesBoard Member
David SchenkeinDavid SchenkeinBoard Member
Marc Tessier-LavigneMarc Tessier-LavigneBoard Member
Alexander SchuthAlexander SchuthCo-Founder
Rivian Automotive
Rivian Automotive
Public14.1k2015Irvine, CA, US
Board Member· Board

Recent news

Redwood Materials loses COO amid layoffs, restructuringTechCrunch · 2026
Slate Auto raises $650M to fund its affordable EV truck plansTechCrunch · 2026
Eclipse backs all-EV marketplace Ever in $31M funding roundTechCrunch · 2026

Leadership at Rivian Automotive

Karen BooneKaren BooneBoard Member
Rose MarcarioRose MarcarioBoard Member
Robert \"RJ\" ScaringeRobert \"RJ\" ScaringeBoard Member
Illumina
Illumina
Public$778M11.5k1998San Diego, CA, US
Board Member· Board

Leadership at Illumina

John ThompsonJohn ThompsonBoard Member
Jacob ThaysenJacob ThaysenBoard Member
Philip SchillerPhilip SchillerBoard Member
Larry BockLarry BockCo-Founder
Gary GuthartGary GuthartBoard Member
Sue SiegelSue SiegelBoard Member

Similar to Illumina

Pacific Biosciences of CaliforniaPacific Biosciences of CaliforniaMenlo Park, CA, USGenetic Analysis, Sequencing Systemsest. 2004Pacific Biosciences of CaliforniaMenlo Park, CA, US · est. 2004

Pacific Biosciences, a CA-based medical firm, designs and manufactures sequencing systems for complex genetic analysis.

Public · $2B769
10x Genomics10x GenomicsPleasanton, CA, USGene Sequencingest. 201210x GenomicsPleasanton, CA, US · est. 2012

10x Genomics: A leading American biotech firm, innovating in gene sequencing since 2012.

Public · $242.6M448
Element BiosciencesElement BiosciencesSan Diego, CA, USGenetic Analysis Toolsest. 2017Element BiosciencesSan Diego, CA, US · est. 2017

San Diego-based biotech firm specializing in the development of genetic analysis tools.

Series C · $401M348
Bionano GenomicsBionano GenomicsSan Diego, CA, USGenome Mapping, Softwareest. 2003Bionano GenomicsSan Diego, CA, US · est. 2003

Bionano Genomics, based in San Diego, offers advanced genome mapping and structural variation detection.

Public · $288.1M405
Iridia
Iridia
Series A$40.1M342016Carlsbad, CA, US
Board Member· Board

Leadership at Iridia

James P. LintonJames P. LintonFounder
Murali PrahaladMurali PrahaladCEO
Helixis
Helixis
Acquired$217.3M02007Carlsbad, CA, US
Board Member· Board

Leadership at Helixis

Alex DickinsonAlex DickinsonFounder
Barry M SchulerBarry M SchulerBoard Member

Jay Flatley's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Jay Flatley

John M LeonardJohn M LeonardBoard Member · Intellia TherapeuticsJohn BoyceJohn BoyceFounder · TigerGeneDon HardisonDon HardisonBoard Member · HTG Molecular DiagnosticsRobert RyanRobert RyanBoard Member · Aegle TherapeuticsFred MermelsteinFred MermelsteinBoard Member · SanaRx BiotherapeuticsSamarth KulkarniSamarth KulkarniBoard Member · Black Diamond Therapeutics